Cached score snapshot
US.COO · Cooper Companies (The)
110分制 46.6/110;5D動能v2 7/50;排序分 53.6/160
Score breakdown
避免
Score and price trend
Main score, 5D momentum v2, close price, and improving or exit-review turn signals are plotted from archived daily snapshots.
Move the mouse over the chart lines to inspect readings.
- Main score
- 5D momentum v2
- Candlestick
- Historical projection
- Score turn
- Setup grade
| Model | Median | P25/P75 | 歷史相似情境上漲比例 | Down5 | Actual / compare |
|---|---|---|---|---|---|
| Rolling DOE best | +1.19% | -0.82% / +3.63% | 58.8% | 0% | Actual outcome pending · 1 / 3 bars observed |
| 30D observation | +8.93% | -0.26% / +15.98% | 73.8% | 10% | Actual outcome pending · 1 / 30 bars observed |
| Historical projection 10D n=160 | +1.58% | -0.85% / +4.64% | 63.8% | 1.9% | Actual outcome pending · 1 / 10 bars observed |
歷史情境統計基於已存檔相似 setup;圖中投影中位線為統計中位數的線性插值展示,並非價格路徑預測或買賣建議。
2026-06-12 → 2026-10-20 · 90 archived points · 2 Improving turn signal · 5 Deteriorating signal
Summary
score_with_momentum_v2 = main score + 5D momentum v2
Rolling setup rating
Setup quality, historical edge, and risk are combined into a rolling S/A/B/C/D/F grade for this snapshot date.
Score turn monitor
Has the score quality changed?
Run more market refreshes to build enough archived points for a turn check.
Signals
技術信號 13.3 · 市場環境 9.6 · 5D動能v2 7
INSTITUTIONAL_DATA_OPTIONAL: Institutional ownership unavailable; neutral money-flow treatment used. FMP_INSTITUTIONAL_FAILED: FMP HTTP 402
Audit trace
Full calculation detail
Calculation detail · 8 sections
Market inputs
Metrics snapshot
110-point main rating
基本面5 + 資金流20 + 市場環境15 + 催化劑20 + 風險管理10 + 技術信號30 + 情緒10
基本面 — 2.1/5 · 較差
Sub-items
資金流 — 8.4/20 · 較差
Sub-items
institutional
details
warning
市場環境 — 9.6/15 · 一般
Sub-items
vix
details
trend
details
qqq
spy
催化劑 — 2/20 · 較差
Sub-items
catalyst
details
風險管理 — 7.2/10 · 良好
Sub-items
position
details
stopLevels
strength_details
diversification
details
技術信號 — 13.3/30 · 較差
Sub-items
vcpPayload
vcp_metrics
情緒分析 — 4/10 · 較差
Sub-items
sentiment
details
sentimentData
Dimension contribution
5D momentum v2 breakdown
Cursor_18.25 5D momentum v2 0-50
Risk management
position
details
stopLevels
strength_details
diversification
details
Calculation audit log
基本面分析總分: 2.1/5分 資金流分析總分: 8.4/20分 市場環境分析總分: 9.6/15分 催化劑分析: 2/20分 風險管理總分: 7.2/10分 技術信號分析總分: 13.3/30分 情緒分析: 4/10分 共振率(僅顯示不加分): 0%
Technical indicators
adx
atr
cci
cmf
kdj
mfi
obv
rsi
sar
ma50
macd
vwap
volume
derived
ma_cross
bollinger
rsi_short
macd_short
volume_ratio
Raw calculation JSON
{
"risk": {
"level": "Medium",
"reason": "risk management score >= 6.5/10",
"position": {
"score": 1.4,
"details": {
"atrPct": 2.2750775594622548,
"turnoverUsdM": 197.98553334000002,
"liquidityPoints": 0.4,
"volatilityPoints": 1
}
},
"rrPoints": 1.4,
"stopLevels": {
"symbol": "US.COO",
"rr_range": "1:1.0-1:2.5",
"risk_profile": "中等",
"stop_loss_price": 64.61,
"strength_details": {
"ma_score": 2,
"atr_score": 2,
"rsi_score": 2.5,
"macd_score": 1,
"volume_score": 2
},
"market_adjustment": 1,
"risk_reward_ratio": 1.2,
"stop_loss_percent": 4.6,
"take_profit_price": 71.2987,
"target_multiplier": 1.9,
"technical_strength": 1.85,
"take_profit_percent": 5.3
},
"positionPoints": 1.4,
"stopLossPoints": 2.4,
"diversification": {
"score": 2,
"details": {
"method": "sector concentration proxy; no portfolio holdings used",
"sector": "Health Care",
"concentratedSectorPenalty": 0
}
},
"riskRewardRatio": 1.2,
"stopLossPercent": 4.5501551189245095,
"diversificationPoints": 2
},
"total": {
"max": 160,
"result": 53.6,
"formula": "score_with_momentum_v2 = main_score + momentum_5d_v2_score",
"baseScore": 46.6,
"modelVersion": "cursor_18_27_news_v2_160",
"momentum5dScore": 7
},
"market": {
"ma20": 73.348,
"ma50": 72.5786,
"close": 67.69,
"prevClose": 69.59,
"avgVolume20": 1674394,
"volumeRatio": 1.75,
"changePercent": -2.73
},
"sources": {
"catalyst": "finnhub_news_keyword_model",
"sentiment": "finnhub_news_keyword_model",
"fundamentals": "fmp_stable",
"institutional": null,
"marketContext": "twelvedata+fred"
},
"barCount": 60,
"momentum": {
"max": 50,
"result": 7,
"details": {
"ret_5d": -0.034241634141340294,
"max_score": 50,
"max_total": 50,
"raw_total": 7,
"vcp_bonus": 0,
"vol_ratio": 1.7754019848857325,
"ret_points": 0,
"vol_points": 6,
"range_ratio": 1.089318189916201,
"volat_points": 0,
"day_range_pct": 0.020534790958782696,
"model_version": "cursor_18_27_news_v2_160",
"available_bars": 30,
"breakout_points": 0,
"partial_history": false,
"pullback_points": 1,
"breakout_vol_bonus": 0,
"first_breakout_20d": false,
"return_window_days": 5,
"first_breakout_bonus": 0,
"breakout_quality_points": 0
},
"formula": "Cursor_18.25 5D momentum v2 0-50",
"modelVersion": "cursor_18_27_news_v2_160"
},
"scoreMax": 110,
"composite": {
"max": 160,
"result": 53.6,
"formula": "Cursor_18.25 ranking score v2 (score_with_momentum_v2)",
"weights": [
{
"raw": 2.1,
"label": "基本面",
"weight": "5/110",
"normalized": 42,
"contribution": 2.1
},
{
"raw": 8.4,
"label": "資金流",
"weight": "20/110",
"normalized": 42,
"contribution": 8.4
},
{
"raw": 9.6,
"label": "市場環境",
"weight": "15/110",
"normalized": 64,
"contribution": 9.6
},
{
"raw": 2,
"label": "催化劑",
"weight": "20/110",
"normalized": 10,
"contribution": 2
},
{
"raw": 7.2,
"label": "風險管理",
"weight": "10/110",
"normalized": 72,
"contribution": 7.2
},
{
"raw": 13.3,
"label": "技術信號",
"weight": "30/110",
"normalized": 44.33,
"contribution": 13.3
},
{
"raw": 4,
"label": "情緒分析",
"weight": "10/110",
"normalized": 40,
"contribution": 4
}
],
"modelVersion": "cursor_18_27_news_v2_160"
},
"momentumMax": 50,
"scoreStatus": "checked",
"standard110": {
"rating": "避免",
"result": 46.6,
"details": [
"基本面分析總分: 2.1/5分",
"資金流分析總分: 8.4/20分",
"市場環境分析總分: 9.6/15分",
"催化劑分析: 2/20分",
"風險管理總分: 7.2/10分",
"技術信號分析總分: 13.3/30分",
"情緒分析: 4/10分",
"共振率(僅顯示不加分): 0%"
],
"formula": "基本面5 + 資金流20 + 市場環境15 + 催化劑20 + 風險管理10 + 技術信號30 + 情緒10",
"dimensionScores": {
"催化劑": 2,
"基本面": 2.1,
"資金流": 8.4,
"市場環境": 9.6,
"情緒分析": 4,
"技術信號": 13.3,
"風險管理": 7.2
},
"dimensionDetails": {
"催化劑": {
"max": 20,
"grade": "較差",
"items": {
"catalyst": {
"score": 2,
"details": {
"source": "finnhub_news_keyword_model",
"articleCount": 8,
"catalystCount": 0
}
},
"catalystPoints": 2
}
},
"基本面": {
"max": 5,
"grade": "較差",
"items": {
"pbPoints": 0.5,
"pePoints": 0.2,
"epsPoints": 0,
"roePoints": 0,
"debtPoints": 0.5,
"marginPoints": 0,
"turnoverUsdM": 197.98553334000002,
"volumePoints": 0.5,
"revenuePoints": 0,
"dividendPoints": 0,
"marketCapPoints": 0.4
},
"source": "fmp_stable"
},
"資金流": {
"max": 20,
"grade": "較差",
"items": {
"cmfPoints": 0.8,
"mfiPoints": 0.8,
"obvPoints": 4,
"vwapPoints": 0.8,
"institutional": {
"score": 2,
"details": {
"source": "optional-neutral",
"warning": {
"code": "INSTITUTIONAL_DATA_OPTIONAL",
"symbol": "US.COO",
"message": "Institutional ownership is unavailable; neutral 2/4 money-flow treatment used."
},
"optional": true,
"holderCount": null,
"holderPoints": 2,
"top10ShareRatio": null,
"concentrationPenalty": 0
}
},
"institutionPoints": 2
}
},
"市場環境": {
"max": 15,
"grade": "一般",
"items": {
"vix": {
"score": 2.4,
"details": {
"source": "twelvedata+fred",
"vixClose": 15.3
}
},
"trend": {
"score": 3.4,
"details": {
"qqq": {
"ma20": 717.3850005500001,
"ma50": 711.3217994399997,
"name": "QQQ",
"close": 718.35999,
"points": 2
},
"spy": {
"ma20": 768.6994929500001,
"ma50": 757.5966012200001,
"name": "SPY",
"close": 765.96002,
"points": 1.4
},
"source": "twelvedata+fred"
}
},
"atrPct": 2.2750775594622548,
"atrPoints": 3,
"cciPoints": 0.8,
"vixPoints": 2.4,
"marketTrendPoints": 3.4
}
},
"情緒分析": {
"max": 10,
"grade": "較差",
"items": {
"sentiment": {
"score": 4,
"details": {
"source": "finnhub_news_keyword_model",
"articleCount": 8,
"negativeHits": 1,
"positiveHits": 3,
"sentimentScoreRaw": 0.6
}
},
"sentimentData": {
"raw": [
{
"id": 141951311,
"url": "https://finnhub.io/api/news?id=0256b934e555accbe6a2da948bd59e3903f849299b1f7b4f2e7c036683c873cb",
"image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
"source": "Yahoo",
"related": "COO",
"summary": "Medical device company CooperCompanies (NASDAQ:COO) will be reporting earnings this Wednesday after market close. Here’s what to expect.",
"category": "company",
"datetime": 1788837891,
"headline": "CooperCompanies (COO) To Report Earnings Tomorrow: Here Is What To Expect"
},
{
"id": 141399367,
"url": "https://finnhub.io/api/news?id=e0b27c9f1bc7ad2cd2f12fe0fc9a555023bc2eaea7837629b0dc523cf0471472",
"image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
"source": "Yahoo",
"related": "COO",
"summary": "Looking beyond Wall Street's top-and-bottom-line estimate forecasts for The Cooper Companies (COO), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the quarter ended July 2026.",
"category": "company",
"datetime": 1788441302,
"headline": "Countdown to The Cooper Companies (COO) Q3 Earnings: Wall Street Forecasts for Key Metrics"
},
{
"id": 141285387,
"url": "https://finnhub.io/api/news?id=8effd4e25ded428825c19395c72f7066a98208572f8a45e5ded21f05ae025e86",
"image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
"source": "Yahoo",
"related": "COO",
"summary": "COO vs. MMSI: Which Stock Is the Better Value Option?",
"category": "company",
"datetime": 1787330403,
"headline": "COO vs. MMSI: Which Stock Is the Better Value Option?"
},
{
"id": 141285388,
"url": "https://finnhub.io/api/news?id=ee2b4f814316ee4eb27e91df536c024a5bdba4cc1171985210712e106377b7c9",
"image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
"source": "Yahoo",
"related": "COO",
"summary": "Analyst projections of slower revenue growth for Cooper Companies (COO), along with past growth projects that did not clear the healthcare sector’s cost of capital, have put the stock’s recent underperformance in sharper focus for investors. See our latest analysis for Cooper Companies. Over the past year Cooper Companies has seen some recovery in its share price, with a 90 day share price return of 21.76% and a 1 year total shareholder return of 1.25%. However, the 3 year and 5 year total...",
"category": "company",
"datetime": 1787285899,
"headline": "Is Cooper Companies (COO) Cheap After Slower Growth Forecasts Raised Valuation Concerns?"
},
{
"id": 141285389,
"url": "https://finnhub.io/api/news?id=2263cc0d315cfaad992af88bfc6ae8eb6e8f17116f7d94059a133b4ccee0668c",
"image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
"source": "Yahoo",
"related": "COO",
"summary": "In recent months, CooperCompanies has faced a softer outlook as analysts now expect its revenue to grow more slowly than in prior years, pointing to potential demand challenges. An important underlying issue is that past growth investments have generated returns below the healthcare industry’s cost of capital, raising fresh questions about how efficiently management is deploying capital. Next, we’ll examine how this weaker revenue growth outlook and capital efficiency concern could reshape...",
"category": "company",
"datetime": 1787275122,
"headline": "Softening Growth And Subpar Returns On Investment Could Be A Game Changer For Cooper (COO)"
},
{
"id": 141285398,
"url": "https://finnhub.io/api/news?id=db6f4a976429ed443549cf106c5814cd4780a0051eada8fe7847a2e5862d807e",
"image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
"source": "Yahoo",
"related": "COO",
"summary": "Cooper Companies stock has delivered a decline of 31.3% over the past five years, yet the current valuation picture is split, with a Discounted Cash Flow (DCF) intrinsic value estimate pointing to attractive upside while earnings based multiples suggest the shares are on the expensive side. Over five years, Cooper Companies has fallen 31.3%, which means long term holders are still under water even after more recent gains. The key support for the current valuation is the market's confidence...",
"category": "company",
"datetime": 1787256559,
"headline": "Cooper Companies (COO) Stock Trades At A Premium To Fair Value"
},
{
"id": 141285390,
"url": "https://finnhub.io/api/news?id=8577845ad17ac526e052028e500a17b3d13161190e1de2784884caecdd5ef777",
"image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
"source": "Yahoo",
"related": "COO",
"summary": "Over the last six months, CooperCompanies’s shares have sunk to $75.74, producing a disappointing 9.5% loss - a stark contrast to the S&P 500’s 12.9% gain. This may have investors wondering how to approach the situation.",
"category": "company",
"datetime": 1787156762,
"headline": "CooperCompanies (COO): Buy, Sell, or Hold Post Q1 Earnings?"
},
{
"id": 141285391,
"url": "https://finnhub.io/api/news?id=e0b9d953643c35a423c8094f91673dbad14dd66af61053dc66b728126651cc14",
"image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
"source": "Yahoo",
"related": "COO",
"summary": "Cooper Companies' 22% three-month surge reflects contact lens share gains, MiSight growth and a recovering fertility business.",
"category": "company",
"datetime": 1787074740,
"headline": "COO Stock Surges 22% in Past Three Months: What's Driving the Uptrend?"
}
],
"raw_source": [
{
"id": 141951311,
"url": "https://finnhub.io/api/news?id=0256b934e555accbe6a2da948bd59e3903f849299b1f7b4f2e7c036683c873cb",
"image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
"source": "Yahoo",
"related": "COO",
"summary": "Medical device company CooperCompanies (NASDAQ:COO) will be reporting earnings this Wednesday after market close. Here’s what to expect.",
"category": "company",
"datetime": 1788837891,
"headline": "CooperCompanies (COO) To Report Earnings Tomorrow: Here Is What To Expect"
},
{
"id": 141438250,
"url": "https://finnhub.io/api/news?id=b32b18f70a2d6d97d3dfacec4155e52722a9bfb88b7fdbe7045235e8b9b7f072",
"image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
"source": "Yahoo",
"related": "COO",
"summary": "HQY's growth is driven by rising HSA assets and AI-led efficiencies, while cybersecurity risks remain a key concern.",
"category": "company",
"datetime": 1788533460,
"headline": "Reasons to Hold HealthEquity Stock in Your Portfolio for Now"
},
{
"id": 141438251,
"url": "https://finnhub.io/api/news?id=5312f8fd75a4bee8e63dde36cadd4968060945ef5f913769b304adbf66335ba5",
"image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
"source": "Yahoo",
"related": "COO",
"summary": "PHG's AI-powered 3D Auto CFQ shows stronger agreement with cardiac MRI than 2D PISA, supporting its cardiovascular ultrasound strategy.",
"category": "company",
"datetime": 1788533100,
"headline": "Philips Shares AI Tool Data for Mitral Regurgitation Assessment at ESC"
},
{
"id": 141402952,
"url": "https://finnhub.io/api/news?id=3d3feccc82059226879876f1951569b64ecda9577a6127905cd7eefbeb5eb152",
"image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
"source": "Yahoo",
"related": "COO",
"summary": "VEEV's strong Q2 results, Vault CRM migrations and AI expansion support growth, while market saturation remains a key concern.",
"category": "company",
"datetime": 1788457140,
"headline": "Reasons to Hold Veeva Systems Stock in Your Portfolio for Now"
},
{
"id": 141402704,
"url": "https://finnhub.io/api/news?id=b3b1ef4df8c77bd564b8c103e476159f06b03899b3c6c49a40a0d45a15c635c7",
"image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
"source": "Yahoo",
"related": "COO",
"summary": "SYK's FDA-cleared SportSuite Vision brings Apple Vision Pro into hip arthroscopy, strengthening its digital surgery push and Sports Medicine portfolio.",
"category": "company",
"datetime": 1788457020,
"headline": "Stryker Launches FDA-Cleared Apple Vision Pro Surgical App"
},
{
"id": 141399367,
"url": "https://finnhub.io/api/news?id=e0b27c9f1bc7ad2cd2f12fe0fc9a555023bc2eaea7837629b0dc523cf0471472",
"image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
"source": "Yahoo",
"related": "COO",
"summary": "Looking beyond Wall Street's top-and-bottom-line estimate forecasts for The Cooper Companies (COO), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the quarter ended July 2026.",
"category": "company",
"datetime": 1788441302,
"headline": "Countdown to The Cooper Companies (COO) Q3 Earnings: Wall Street Forecasts for Key Metrics"
},
{
"id": 141380178,
"url": "https://finnhub.io/api/news?id=2b8d1aacd8f484827e4d64710c3d4f8e5e1c531af9bc90fd4134f334d7300c3e",
"image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
"source": "Yahoo",
"related": "COO",
"summary": "ENOV is set to acquire eCential Robotics to expand into orthopedic surgical robotics, though the deal is expected to pressure 2027 margins.",
"category": "company",
"datetime": 1788373980,
"headline": "Enovis Boosts Surgical Robotics Portfolio With eCential Acquisition"
},
{
"id": 141369419,
"url": "https://finnhub.io/api/news?id=4bd86a988eee4c33fde06d22a28a6737f81f8890d6785a55ea35331324c27c98",
"image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1820742209/image_1820742209.jpg?io=getty-c-w1536",
"source": "SeekingAlpha",
"related": "COO",
"summary": "Cooper Companies (COO) outlook: premium lens growth, margin gains, stronger cash flow & possible CooperSurgical sale. Click here to read my latest analysis.",
"category": "company",
"datetime": 1788271357,
"headline": "Cooper Companies: Cash Conversion And Strategic Optionality Create A Re-Rating Setup"
},
{
"id": 141365559,
"url": "https://finnhub.io/api/news?id=d58555be66b9153b3509317d8f0bfffb9ece0b3b3d239d0aee4d7fadfd2d4453",
"image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
"source": "Yahoo",
"related": "COO",
"summary": "Ostrom Climate Solutions Inc. (\"Ostrom\" or the \"Company\") (TSXV: COO) (Frankfurt: 9EAA), a leading provider of carbon project development, net-zero climate solutions, and carbon credit marketing and trading, today announced its unaudited financial results for the second quarter ended June 30, 2026.",
"category": "company",
"datetime": 1787967300,
"headline": "OSTROM CLIMATE REPORTS FISCAL Q2 2026 FINANCIAL STATEMENTS"
},
{
"id": 141364000,
"url": "https://finnhub.io/api/news?id=37a72908f114871f1a4dad46f9fc801a4f8980f63b77c0174b1008921028a865",
"image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
"source": "Yahoo",
"related": "COO",
"summary": "CVRX secures Devoted Health Medicare Advantage coverage for Barostim, expanding reimbursement access to about 466,000 members across 29 states.",
"category": "company",
"datetime": 1787935140,
"headline": "CVRx Secures Devoted Health Coverage for Barostim Therapy"
},
{
"id": 141365561,
"url": "https://finnhub.io/api/news?id=6a40905df7f445dc78f726199748517e4546d4a7186f78375096b3faa160f6ea",
"image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
"source": "Yahoo",
"related": "COO",
"summary": "Many investors pay attention to mid-cap stocks because they have established business models and expansive market opportunities. However, their paths to becoming $100 billion corporations are ripe with competition, ranging from giants with vast resources to agile upstarts eager to disrupt the status quo.",
"category": "company",
"datetime": 1787923972,
"headline": "1 Mid-Cap Stock with Impressive Fundamentals and 2 Facing Challenges"
},
{
"id": 141364236,
"url": "https://finnhub.io/api/news?id=5e22d4a74cec5831ef1bd013a9cb7f136d6596bc1e6054a8fc66b2fcd85827ce",
"image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
"source": "Yahoo",
"related": "COO",
"summary": "VEEV's Q2 fiscal 2027 earnings and revenues top estimates, while strong Vault CRM momentum and a raised full-year outlook drive shares higher.",
"category": "company",
"datetime": 1787848260,
"headline": "Veeva Systems Q2 Earnings and Revenues Beat Estimates, Stock Up"
},
{
"id": 141317763,
"url": "https://finnhub.io/api/news?id=d9a2b22a4880b4c57a5a78e197c6c5ce8a510e121a48982bd29dab32dc155385",
"image": "https://www.chartmill.com/images/uploads/CM_Top_Movers_Small_free_2b4ff2fc22.webp",
"source": "ChartMill",
"related": "COO",
"summary": "Wondering what's happening in today's session for the S&P500 index? Stay informed with the top movers within the S&P500 index on Tuesday.",
"category": "company",
"datetime": 1787684701,
"headline": "Top S&P500 movers in Tuesday's session"
},
{
"id": 141314075,
"url": "https://finnhub.io/api/news?id=cffee9de1f9c3c33dbc7f50b1cfc92908d0a7791b14fc63ba2cec5a04d3d6cb8",
"image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1285071364/image_1285071364.jpg?io=getty-c-w1536",
"source": "SeekingAlpha",
"related": "COO",
"summary": "Embecta (EMBC) looks like a deep value buy: P/E under 3x, 50%+ FCF yield, insider buying and rebound setup.",
"category": "company",
"datetime": 1787613074,
"headline": "The Bottom Fishing Club - Embecta: Excellent Turnaround Prospect In Defensive Medical Products"
},
{
"id": 141364562,
"url": "https://finnhub.io/api/news?id=2e2a954efd2b15fc6a53a148619420c96b95f9f5a88d883a2f3870eb742f848e",
"image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
"source": "Yahoo",
"related": "COO",
"summary": "GE HealthCare's record backlog, strong Pharmaceutical Diagnostics growth and AI innovation support its growth outlook despite margin pressures.",
"category": "company",
"datetime": 1787592420,
"headline": "Here's Why You Should Add GEHC Stock to Your Portfolio for Now"
},
{
"id": 141365557,
"url": "https://finnhub.io/api/news?id=b60761c0d6bf3be1dac107ed638f629e5721c81459d1282b53c6579bbdfd700c",
"image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
"source": "Yahoo",
"related": "COO",
"summary": "Cooper Companies has underperformed the broader market over the past year, and analysts remain somewhat optimistic about the stock’s prospects.",
"category": "company",
"datetime": 1787581657,
"headline": "Are Wall Street Analysts Bullish on Cooper Companies Stock?"
},
{
"id": 141365558,
"url": "https://finnhub.io/api/news?id=aadfdde577c30bc7effe7096f2d78b4eb7a56e79c4198dfbdc5ab8560dac9910",
"image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
"source": "Yahoo",
"related": "COO",
"summary": "Personal health and wellness is one of the many secular tailwinds for healthcare companies. Players catalyzing medical advancements have benefited from elevated demand, and their momentum is only rising as the industry has posted a 28.9% gain over the past six months, beating the S&P 500 by 18 percentage points.",
"category": "company",
"datetime": 1787580816,
"headline": "1 Healthcare Stock to Target This Week and 2 Facing Headwinds"
},
{
"id": 141283982,
"url": "https://finnhub.io/api/news?id=c4b2da463c6f09a31ce8e17d294cbf1644931a45b43de4a4e12c8f1e77ee8f38",
"image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
"source": "Yahoo",
"related": "COO",
"summary": "INGN's POC demand, new products and international growth support its outlook, while U.S. channel shifts and distributor timing pose risks.",
"category": "company",
"datetime": 1787330760,
"headline": "Here's Why You Should Retain Inogen Stock in Your Portfolio for Now"
},
{
"id": 141278125,
"url": "https://finnhub.io/api/news?id=c4219d4c8cc06018c3099f6575c54f4f5c3fca8777f4943262f105bf447c2dec",
"image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
"source": "Yahoo",
"related": "COO",
"summary": "JNJ's MONARCH QUEST 3 wins FDA 510(k) clearance, adding AI-powered planning, navigation and imaging upgrades for robotic bronchoscopy.",
"category": "company",
"datetime": 1787330580,
"headline": "Johnson & Johnson Wins FDA 510(k) Clearance for MONARCH QUEST 3 Update"
},
{
"id": 141285387,
"url": "https://finnhub.io/api/news?id=8effd4e25ded428825c19395c72f7066a98208572f8a45e5ded21f05ae025e86",
"image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
"source": "Yahoo",
"related": "COO",
"summary": "COO vs. MMSI: Which Stock Is the Better Value Option?",
"category": "company",
"datetime": 1787330403,
"headline": "COO vs. MMSI: Which Stock Is the Better Value Option?"
},
{
"id": 141283984,
"url": "https://finnhub.io/api/news?id=b75563b5894b58e0887a3679e9fdda1971893a4221c73767729b846b337b105a",
"image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
"source": "Yahoo",
"related": "COO",
"summary": "Inspire Medical stock's 39.7% three-month surge is driven by the easing of reimbursement pressures, increasing Inspire V adoption and Project Horizon targeting longer-term expansion.",
"category": "company",
"datetime": 1787330040,
"headline": "INSP Stock Rallies Nearly 40% YTD: Can Its Growth Story Continue?"
},
{
"id": 141283985,
"url": "https://finnhub.io/api/news?id=b73e213a06b8ca1cf8c2e1fb47c041c4ea799d097e88e7a558e805c84d3ec268",
"image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
"source": "Yahoo",
"related": "COO",
"summary": "BTSG's nearly 59% YTD surge is backed by 23% revenue growth, rising margins and expansion in specialty pharmacy and home-based care.",
"category": "company",
"datetime": 1787329800,
"headline": "BrightSpring Stock Up Nearly 59% YTD: Can Its Growth Story Continue?"
},
{
"id": 141279656,
"url": "https://finnhub.io/api/news?id=5f941718a2b3dcd6c642c392d28f14263bd1e17229ca84c001ef41096bad7251",
"image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
"source": "Yahoo",
"related": "COO",
"summary": "SYK's resilient demand, Mako robotics growth and margin gains support its outlook despite cyber and supply disruptions.",
"category": "company",
"datetime": 1787328720,
"headline": "Here's Why You Should Hold Stryker Stock in Your Portfolio for Now"
},
{
"id": 141285388,
"url": "https://finnhub.io/api/news?id=ee2b4f814316ee4eb27e91df536c024a5bdba4cc1171985210712e106377b7c9",
"image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
"source": "Yahoo",
"related": "COO",
"summary": "Analyst projections of slower revenue growth for Cooper Companies (COO), along with past growth projects that did not clear the healthcare sector’s cost of capital, have put the stock’s recent underperformance in sharper focus for investors. See our latest analysis for Cooper Companies. Over the past year Cooper Companies has seen some recovery in its share price, with a 90 day share price return of 21.76% and a 1 year total shareholder return of 1.25%. However, the 3 year and 5 year total...",
"category": "company",
"datetime": 1787285899,
"headline": "Is Cooper Companies (COO) Cheap After Slower Growth Forecasts Raised Valuation Concerns?"
},
{
"id": 141285389,
"url": "https://finnhub.io/api/news?id=2263cc0d315cfaad992af88bfc6ae8eb6e8f17116f7d94059a133b4ccee0668c",
"image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
"source": "Yahoo",
"related": "COO",
"summary": "In recent months, CooperCompanies has faced a softer outlook as analysts now expect its revenue to grow more slowly than in prior years, pointing to potential demand challenges. An important underlying issue is that past growth investments have generated returns below the healthcare industry’s cost of capital, raising fresh questions about how efficiently management is deploying capital. Next, we’ll examine how this weaker revenue growth outlook and capital efficiency concern could reshape...",
"category": "company",
"datetime": 1787275122,
"headline": "Softening Growth And Subpar Returns On Investment Could Be A Game Changer For Cooper (COO)"
},
{
"id": 141285398,
"url": "https://finnhub.io/api/news?id=db6f4a976429ed443549cf106c5814cd4780a0051eada8fe7847a2e5862d807e",
"image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
"source": "Yahoo",
"related": "COO",
"summary": "Cooper Companies stock has delivered a decline of 31.3% over the past five years, yet the current valuation picture is split, with a Discounted Cash Flow (DCF) intrinsic value estimate pointing to attractive upside while earnings based multiples suggest the shares are on the expensive side. Over five years, Cooper Companies has fallen 31.3%, which means long term holders are still under water even after more recent gains. The key support for the current valuation is the market's confidence...",
"category": "company",
"datetime": 1787256559,
"headline": "Cooper Companies (COO) Stock Trades At A Premium To Fair Value"
},
{
"id": 141281778,
"url": "https://finnhub.io/api/news?id=e7adcedb141ab46bd93163e2536b035f1d90bc75f1cf4cfe9ac78f80f75695ff",
"image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
"source": "Yahoo",
"related": "COO",
"summary": "BD concludes PREVENT trial enrollment, advancing Phasix Mesh toward a potential FDA submission for incisional hernia prevention.",
"category": "company",
"datetime": 1787246580,
"headline": "BDX Completes PREVENT Trial Enrollment for Phasix Mesh Study"
},
{
"id": 141266860,
"url": "https://finnhub.io/api/news?id=db611a64fbf03b230be4b5b782e1bab7a0378c9f276b9bc20f8b0c7c17ff967e",
"image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
"source": "Yahoo",
"related": "COO",
"summary": "MMED's MiniMed Flex is now shipping in the U.S. with Abbott's 15-day Instinct sensor, pairing discreet app control with automated insulin delivery.",
"category": "company",
"datetime": 1787246040,
"headline": "MiniMed Ships MiniMed Flex With Abbott's Smallest Instinct Sensor"
},
{
"id": 141283992,
"url": "https://finnhub.io/api/news?id=37eb4fb3fb259704bc8889e42d9c66402dc8110e9f56566c62af937ffc38bd2e",
"image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
"source": "Yahoo",
"related": "COO",
"summary": "Hinge Health's nearly 90% YTD surge is backed by 53% revenue growth, wider margins and expansion into migraine and GI care, but execution risks remain.",
"category": "company",
"datetime": 1787162100,
"headline": "HNGE Stock Surges Nearly 90% YTD: Can Its Growth Story Continue?"
},
{
"id": 141279330,
"url": "https://finnhub.io/api/news?id=30e482ac66f335fd06f9335323ecea233f86b3fec37689483b7273b323f2c7d1",
"image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
"source": "Yahoo",
"related": "COO",
"summary": "ISRG is expanding in Asia Pacific with a new Penang plant to boost capacity and support rising demand for robotic-assisted surgery.",
"category": "company",
"datetime": 1787161080,
"headline": "Intuitive Surgical Expands Manufacturing Footprint in Asia Pacific"
},
{
"id": 141285390,
"url": "https://finnhub.io/api/news?id=8577845ad17ac526e052028e500a17b3d13161190e1de2784884caecdd5ef777",
"image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
"source": "Yahoo",
"related": "COO",
"summary": "Over the last six months, CooperCompanies’s shares have sunk to $75.74, producing a disappointing 9.5% loss - a stark contrast to the S&P 500’s 12.9% gain. This may have investors wondering how to approach the situation.",
"category": "company",
"datetime": 1787156762,
"headline": "CooperCompanies (COO): Buy, Sell, or Hold Post Q1 Earnings?"
},
{
"id": 141283994,
"url": "https://finnhub.io/api/news?id=7118fcfc455dcfff25cf8dd09c68938daf08dd78c9ed045f17f2c2487c7c2d8d",
"image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
"source": "Yahoo",
"related": "COO",
"summary": "Glaukos' iDose TR and Epioxa are driving rapid growth, while margin expansion and a broad pipeline strengthen its long-term prospects.",
"category": "company",
"datetime": 1787152500,
"headline": "Here's Why You Should Retain Glaukos Stock in Your Portfolio for Now"
},
{
"id": 141285391,
"url": "https://finnhub.io/api/news?id=e0b9d953643c35a423c8094f91673dbad14dd66af61053dc66b728126651cc14",
"image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
"source": "Yahoo",
"related": "COO",
"summary": "Cooper Companies' 22% three-month surge reflects contact lens share gains, MiSight growth and a recovering fertility business.",
"category": "company",
"datetime": 1787074740,
"headline": "COO Stock Surges 22% in Past Three Months: What's Driving the Uptrend?"
},
{
"id": 141249262,
"url": "https://finnhub.io/api/news?id=cd84f8231493ebb18fccd9f4632072f388ae813ad5bb247d4545f99f0bf939a5",
"image": "https://cdn.benzinga.com/files/images/story/2026/08/18/Everpure-logo-site.png?width=2048&height=1536",
"source": "Benzinga",
"related": "COO",
"summary": "Jana Partners adds Everpure stock, a growing player in AI and data center market, to its portfolio. It also lowers its stake in other companies.",
"category": "company",
"datetime": 1787059139,
"headline": "Jana Partners Buys Stake in Data Center Stock Everpure, May Be Up Almost 100% Already"
},
{
"id": 141250275,
"url": "https://finnhub.io/api/news?id=72aa3033993c9773bbace7800f1af4af161f6496b542780f6d21fdea95613697",
"image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
"source": "Yahoo",
"related": "COO",
"summary": "NTRA is using its Latitude MRD test in Kupando's Phase 1 skin cancer trial to track ctDNA and characterize response to KUP-101.",
"category": "company",
"datetime": 1786985040,
"headline": "Natera Supports Kupando Trial to Advance ctDNA Monitoring in Cancer"
},
{
"id": 141282326,
"url": "https://finnhub.io/api/news?id=faba776873e4e4ba41ecf84efb154c62932d2516ceb5780783fee8a9aea8c157",
"image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
"source": "Yahoo",
"related": "COO",
"summary": "The S&P 500 (^GSPC) is often seen as a benchmark for strong businesses, but that doesn’t mean every stock is worth owning. Some companies face significant challenges, whether it’s stagnating growth, heavy debt, or disruptive new competitors.",
"category": "company",
"datetime": 1786891260,
"headline": "3 S&P 500 Stocks We Think Twice About"
},
{
"id": 141212274,
"url": "https://finnhub.io/api/news?id=b010713295d26ccd8ae361023b5941c321a3e7758d3f55adeb75362852ecfef6",
"image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
"source": "Yahoo",
"related": "COO",
"summary": "HeartFlow (HTFL) delivered earnings and revenue surprises of +50.00% and +12.96%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?",
"category": "company",
"datetime": 1786656902,
"headline": "HeartFlow (HTFL) Reports Q2 Loss, Beats Revenue Estimates"
},
{
"id": 141212060,
"url": "https://finnhub.io/api/news?id=025d57b24590603cb45cf65794b22e0e767d236458c1dda40e82ea69a03ca747",
"image": "",
"source": "Benzinga",
"related": "COO",
"summary": "Citigroup analyst Joanne Wuensch maintains Cooper Companies (NASDAQ:COO) with a Neutral and raises the price target from $76 to $80.",
"category": "company",
"datetime": 1786639245,
"headline": "Citigroup Maintains Neutral on Cooper Companies, Raises Price Target to $80"
},
{
"id": 141205666,
"url": "https://finnhub.io/api/news?id=6ffa1b74e3016ee2e16dcae1b326a2ce32afa731ce1bdc8b5deda915bb26d23a",
"image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
"source": "Yahoo",
"related": "COO",
"summary": "Cooper Companies' premium lens migration, MiSight growth and fertility recovery offer long-term upside despite Asia-Pacific, tariff and FX pressures.",
"category": "company",
"datetime": 1786625460,
"headline": "Here's Why You Should Add Cooper Companies Stock to Your Portfolio Now"
},
{
"id": 141202656,
"url": "https://finnhub.io/api/news?id=1465d58e14aa3519a86a6ba0218b0d69cd6cbb5ace1244b8ffb95a68f77f700c",
"image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
"source": "Yahoo",
"related": "COO",
"summary": "Staar Surgical (STAA) delivered earnings and revenue surprises of +47.62% and +3.05%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?",
"category": "company",
"datetime": 1786569002,
"headline": "Staar Surgical (STAA) Surpasses Q2 Earnings and Revenue Estimates"
},
{
"id": 141202469,
"url": "https://finnhub.io/api/news?id=e0277f3fb832d7629b5cfa40809a7c12d4b0dd92ab901d8e20bba9889d3940ae",
"image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
"source": "Yahoo",
"related": "COO",
"summary": "NeuroPace's Q2 revenues rise 17.1% as RNS demand strengthens, while a narrower loss and higher 2026 outlook highlight continued momentum.",
"category": "company",
"datetime": 1786548120,
"headline": "NPCE Q2 Earnings Beat Estimates on RNS Growth, '26 Revenue View Up"
},
{
"id": 141202034,
"url": "https://finnhub.io/api/news?id=c70632c2f9259acf971a4ff2e21f3a79f70231e7041cbbc36844dbb90356e0cf",
"image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
"source": "Yahoo",
"related": "COO",
"summary": "Cardinal Health beats fiscal Q4 EPS estimates as profit surges, while revenues miss; fiscal 2027 guidance points to continued earnings growth.",
"category": "company",
"datetime": 1786465260,
"headline": "CAH Q4 Earnings Beat on Pharma Strength, Revenues Miss, Stock Up"
},
{
"id": 141202043,
"url": "https://finnhub.io/api/news?id=211c1e69d0f065f870c9c010a432db201c6207fc440f7474867a1efe9b423f3a",
"image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
"source": "Yahoo",
"related": "COO",
"summary": "Cardinal (CAH) delivered earnings and revenue surprises of +20.25% and -2.96%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?",
"category": "company",
"datetime": 1786449302,
"headline": "Cardinal Health (CAH) Q4 Earnings Beat Estimates"
},
{
"id": 141177784,
"url": "https://finnhub.io/api/news?id=2b214d626c55d69f3321fcb009f6866c20e2d848f4d640c809751929b9c57eb4",
"image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
"source": "Yahoo",
"related": "COO",
"summary": "INGN's Q2 revenues rise 3% as international sales climb 14.8%, but U.S. weakness led it to cut its 2026 revenue outlook.",
"category": "company",
"datetime": 1786380840,
"headline": "Inogen Q2 Earnings Beat Estimates, Sales Rise Y/Y, 2026 View Cut"
}
],
"data_source": "finnhub_news_keyword_model",
"article_count": 8,
"negative_hits": 1,
"positive_hits": 3,
"recomputed_at_score": true,
"sentiment_score_raw": 0.6,
"source_article_count": 44,
"discarded_article_count": 36
},
"sentimentPoints": 4
}
},
"技術信號": {
"max": 30,
"raw": 13.3,
"grade": "較差",
"items": {
"bbPoints": 2.4,
"adxPoints": 3,
"sarPoints": 1.2000000000000002,
"vcpPoints": 0.6,
"macdPoints": 0.8,
"vcpPayload": {
"vcp_pass": false,
"vcp_score": 0.6,
"vcp_reason": "跌縮量(近10日4日);Ready=N;Confirm=N",
"vcp_metrics": {
"up_days": 3,
"vol_ref": 1745630,
"down_days": 6,
"vcp_ready": false,
"above_ma50": false,
"avg_vol_10": 1581910,
"avg_vol_20": 1647450,
"avg_vol_30": 1745630,
"range_pct_10": 0.11079920224553118,
"range_pct_20": 0.13340224553109775,
"range_pct_30": 0.13340224553109775,
"up_expand_ok": false,
"lookback_used": 59,
"near_20d_high": false,
"contraction_ok": false,
"down_shrink_ok": true,
"up_expand_days": 1,
"breakout_20d_ok": false,
"vol_ratio_10_30": 0.9062115110304017,
"dist_to_20d_high": 0.1334016131097171,
"down_shrink_days": 4,
"breakout_level_20d": 78.11,
"vcp_breakout_confirm": false,
"contraction_ratio_10_30": 0.8305647465259682
},
"vcp_name_en": "Volatility Contraction Pattern",
"vcp_name_zh": "波動收縮形態",
"vol_contraction": false
},
"kdjAdxPoints": 0.5,
"rsiKdjPoints": 0.8,
"volumeWeight": 2,
"maCrossPoints": 2.4,
"shortRsiPoints": 0,
"shortMacdPoints": 0.4,
"volConfirmPoints": 0,
"volumePointsTechnical": 1.2
}
},
"風險管理": {
"max": 10,
"grade": "良好",
"items": {
"position": {
"score": 1.4,
"details": {
"atrPct": 2.2750775594622548,
"turnoverUsdM": 197.98553334000002,
"liquidityPoints": 0.4,
"volatilityPoints": 1
}
},
"rrPoints": 1.4,
"stopLevels": {
"symbol": "US.COO",
"rr_range": "1:1.0-1:2.5",
"risk_profile": "中等",
"stop_loss_price": 64.61,
"strength_details": {
"ma_score": 2,
"atr_score": 2,
"rsi_score": 2.5,
"macd_score": 1,
"volume_score": 2
},
"market_adjustment": 1,
"risk_reward_ratio": 1.2,
"stop_loss_percent": 4.6,
"take_profit_price": 71.2987,
"target_multiplier": 1.9,
"technical_strength": 1.85,
"take_profit_percent": 5.3
},
"positionPoints": 1.4,
"stopLossPoints": 2.4,
"diversification": {
"score": 2,
"details": {
"method": "sector concentration proxy; no portfolio holdings used",
"sector": "Health Care",
"concentratedSectorPenalty": 0
}
},
"riskRewardRatio": 1.2,
"stopLossPercent": 4.5501551189245095,
"diversificationPoints": 2
}
}
}
},
"modelVersion": "cursor_18_27_news_v2_160",
"providerErrors": [],
"rankingScoreMax": 160,
"dataCompleteness": {
"complete": true,
"missingFields": [],
"optionalInputs": [
"institutionalData"
],
"requiredInputs": [
"fundamentals",
"marketContext.VIX",
"marketContext.SPY",
"marketContext.QQQ",
"catalystData",
"sentimentData",
"ATR",
"sector"
],
"optionalInputWarnings": []
},
"technicalIndicators": {
"adx": 78.57,
"atr": {
"atr": 1.54,
"rule": "ATR / current price; lower volatility scores higher",
"score": 6,
"atr_pct": 2.28
},
"cci": {
"rule": "Cursor_18.24 CCI bands",
"level": "超買或超賣風險",
"score": 2,
"value": -126.22
},
"cmf": {
"rule": "Cursor_18.24 CMF bands",
"level": "派發",
"score": 2,
"value": -0.322
},
"kdj": {
"d": 10.96,
"j": 1.61,
"k": 7.84,
"rule": "Cursor_18.24 K/D cross",
"score": 0,
"signal": "死叉"
},
"mfi": {
"rule": "Cursor_18.24 MFI bands",
"level": "超賣或超買風險",
"score": 2,
"value": 22.3
},
"obv": {
"rule": "Cursor_18.24 recent_slope vs previous_slope",
"score": 10,
"trend": "強流入",
"value": 2206514,
"recentSlope": -679018.6,
"previousSlope": -598750
},
"rsi": 19.59,
"sar": {
"rule": "Cursor_18.24 Parabolic SAR",
"score": 4,
"trend": "下降",
"value": 73.2884,
"position": "SAR喺價上",
"distancePct": 8.27,
"previousTrend": "下降"
},
"ma50": 72.5786,
"macd": {
"macd": -1.160197162553871,
"trend": "看跌",
"signal": -0.40086233124439863,
"histogram": -0.7593348313094723
},
"vwap": {
"rule": "Cursor_18.24 VWAP 20D consecutive close",
"score": 2,
"value": 73.2087,
"position": "<VWAP",
"consecutiveAbove": 0
},
"volume": {
"rule": "Cursor_18.24 volume ratio",
"level": "有量",
"ratio": 1.75,
"score": 6,
"avgVolume": 1674394,
"currentVolume": 2924886
},
"derived": {
"ma20": 73.348,
"ma50": 72.5786,
"prevClose": 69.59,
"avgVolume10": 1760329,
"avgVolume20": 1674394,
"changePercent": -2.73,
"avgVolumeForScore": 1674394
},
"ma_cross": {
"ma20": 73.348,
"ma50": 72.5786,
"rule": "Cursor_18.24 MA20/MA50 cross",
"cross": "接近",
"score": 6,
"prevMa20": 73.7795,
"prevMa50": 72.6452,
"spreadPct": 1.06,
"isVolumeBreakout": true
},
"bollinger": {
"lower": 67.196,
"upper": 79.5,
"position": "中間"
},
"rsi_short": 21.94,
"macd_short": {
"macd": 0,
"trend": "中性",
"signal": 0,
"histogram": 0
},
"volume_ratio": {
"ratio": 1.75
}
}
}
Raw metrics JSON
{
"close": 67.69,
"volume": 2924886,
"changePercent": -2.73
}
Scores are derived from cached daily market data using the Cursor_18.25 standard. Solorank.ai provides research support only and does not provide financial advice or buy/sell recommendations.